β1-adrenergic receptor gene polymorphisms and the acute response to atenolol in healthy young Japanese subjects

DOI Web Site 参考文献70件
  • Sasaguri Toshiyuki
    Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Japan
  • Shiraishi Fumie
    Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Japan
  • Yoshihara Tatsuya
    Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Japan
  • Takahashi-Yanaga Fumi
    Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Japan
  • Morimoto Sachio
    Department of Clinical Pharmacology, Faculty of Medical Sciences, Kyushu University, Japan

書誌事項

タイトル別名
  • .BETA.1-Adrenergic Receptor Gene Polymorphisms and the Acute Response to Atenolol in Healthy Young Japanese Subjects
  • v 1 adrenergic receptor gene polymorphisms and the acute response to atenolol in healthy young Japanese subjects

この論文をさがす

抄録

Polymorphisms at codons 49 and 389 of the β1-adrenergic receptor gene have been shown to alter the receptor function in vitro, whereas it remains controversial whether they influence the response to β-blocker in vivo. In the present study, we investigated whether these polymorphisms influence the acute changes of heart rate and blood pressure induced by the β1-adrenergic receptor–selective blocker atenolol in healthy young Japanese. A double-blind study was conducted with 307 subjects randomly allocated 2:1 to atenolol (50 mg) or placebo groups. Heart rate and blood pressure were significantly reduced after administration of atenolol in comparison to the placebo. In 207 subjects allocated to the atenolol group, the numbers of Ser/Ser, Ser/Gly, and Gly/Gly allele carriers for codon 49 were 159, 46, and 2, respectively; and those of Arg/Arg, Arg/Gly, and Gly/Gly for codon 389 were 129, 66, and 12, respectively. No significant association was identified between the changes in heart rate or blood pressure and either of the two polymorphisms. There was also no difference in the changes in heart rate or blood pressure among the diplotypes. The results of the present study do not support clinical use of genotyping for these polymorphisms to predict responses to β-blockers.

収録刊行物

参考文献 (70)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ